KCM
LUCD icon

Kornitzer Capital Management’s Lucid Diagnostics LUCD Stock Holding History

Kornitzer Capital Management’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-133,000
Closed -$181K – 494
2022
Q4 		$181K Hold
133,000
– – ﹤0.01% 496
2022
Q3 		$203K Hold
133,000
– – ﹤0.01% 500
2022
Q2 		$301K Hold
133,000
– – 0.01% 490
2022
Q1 		$447K Hold
133,000
– – 0.01% 483
2021
Q4 		$714K Buy
+133,000
New +$1.08M 0.01% 463

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Kornitzer Capital Management's LUCD Position: Q1 2023 in Review

Kornitzer Capital Management sold out of Lucid Diagnostics (LUCD) in Q1 2023, closing a stake of 133,000 shares — an estimated $181K sold.

Kornitzer Capital Management first reported a position in LUCD in Q4 2021 and held it in 5 quarters. The position peaked at $714K in Q4 2021. 19 funds tracked by Wall St. Rank hold LUCD as of Q1 2023.

  • Kornitzer Capital Management reported no remaining Lucid Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Kornitzer Capital Management sold 133,000 Lucid Diagnostics shares in Q1 2023, an estimated $181K.
  • Kornitzer Capital Management first reported a position in Lucid Diagnostics in Q4 2021 and held it in 5 quarters.
  • Kornitzer Capital Management's Lucid Diagnostics position peaked at $714K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2023.

Based on Kornitzer Capital Management's 13F filing for Q1 2023, filed 9 May 2023.